FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation

被引:36
作者
O'Conner, AR
Franc, BL
机构
[1] Univ Calif San Francisco, Dept Radiol, Nucl Med Program, San Francisco, CA 94143 USA
[2] City Hosp Nottingham, Dept Radiol, Nottingham, England
关键词
PTLD; PET; renal; staging; follow-up;
D O I
10.1097/00006231-200512000-00010
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives To assess the usefulness of fluorodeoxyglucose positron emission tomography (FDG PET) in the evaluation of post-transplant lymphoproliferative disorder (PTLD) following renal transplantation. Methods Staging FDG PET examinations were reviewed in five patients with biopsy proven post-renal allograft PTLD and compared with conventional imaging. Follow-up PET examinations of three patients at various points during their therapy for PTLD were also reviewed and compared with clinical outcome. Results PET imaging identified all disease sites seen at cross-sectional imaging, clarified sites of uncertain significance and detected additional disease in two out of five patients. Early follow-up imaging impacted PTLD management in two of three patients. Conclusion In this limited series FDG PET was an effective imaging modality in the staging and follow-up of PTLD. Nucl Med Commun 26:1107-1111 (c) 2005 Lippincott Williams & Wilkins.
引用
收藏
页码:1107 / 1111
页数:5
相关论文
共 9 条
[1]   Early onset post-transplant lymphoproliferative disease is associated with allograft localization [J].
Bakker, NA ;
van Imhoff, GW ;
Verschuuren, EAM ;
van Son, WJ ;
van der Heide, JJH ;
Veeger, NJGM ;
Kluin, PM ;
Kluin-Nelemans, HC .
CLINICAL TRANSPLANTATION, 2005, 19 (03) :327-334
[2]   Post-transplant lymphoproliferative disorders [J].
Gottschalk, S ;
Rooney, CM ;
Heslop, HE .
ANNUAL REVIEW OF MEDICINE, 2005, 56 :29-44
[3]   [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma:: an early prognostic tool for predicting patient outcome [J].
Haioun, C ;
Itti, E ;
Rahmouni, A ;
Brice, P ;
Rain, JD ;
Belhadj, K ;
Gaulard, P ;
Garderet, L ;
Lepage, E ;
Reyes, F ;
Meignan, M .
BLOOD, 2005, 106 (04) :1376-1381
[4]   Positron emission tomography in the evaluation of lymphoma [J].
Israel, O ;
Keidar, Z ;
Bar-Shalom, R .
SEMINARS IN NUCLEAR MEDICINE, 2004, 34 (03) :166-179
[5]   Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas [J].
Kumar, R ;
Maillard, I ;
Schuster, SJ ;
Alavi, A .
RADIOLOGIC CLINICS OF NORTH AMERICA, 2004, 42 (06) :1083-+
[6]  
PENN I, 1991, TRANSPLANT P, V23, P1101
[7]   Posttransplantation lymphoproliferative disorder in children: Clinical, histopathologic, and imaging features [J].
Pickhardt, PJ ;
Siegel, MJ ;
Hayashi, RJ ;
Kelly, M .
RADIOLOGY, 2000, 217 (01) :16-25
[8]   Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: The Israel Penn international transplant tumor registry experience [J].
Trofe, J ;
Buell, JF ;
Beebe, TM ;
Hanaway, MJ ;
First, MR ;
Alloway, RR ;
Gross, TG ;
Succop, P ;
Woodle, ES .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (04) :775-780
[9]  
*WHO, 2001, PATH GEN TUM HEM LYM, P1221